741 Pivotal phase 3 study in overactive bladder (OAB) patients with urinary incontinence confirms onabotulinumtoxinA 100U significantly improves all OAB symptoms and patients' quality of life

✍ Scribed by Chapple, C.; Sievert, K-D.; MacDiarmid, S.; Khullar, V.; Radziszewski, P.; Nardo, C.; Thompson, C.; Zhou, J.; Haag-Molkenteller, C.

• Book ID: 122642938
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 98 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)61223-3